AboutValuesWhy OA.mg?OA.mg PremiumExploreDataContact
Chrome ExtensionScholarMindChatGPT Plugin
ϟ
 
DOI: 10.1002/jps.24162
OpenAccess: Closed
This work is not Open Acccess. We may still have a PDF, if this is the case there will be a green box below.

The Biopharmaceutics Risk Assessment Roadmap for Optimizing Clinical Drug Product Performance

Arzu Selen,Paul Dickinson,Anette Müllertz,John R. Crison,Hitesh Mistry,María T. Cruañes,Marilyn N. Martinez,Hans Lennernäs,Tim Wigal,David C. Swinney,James E. Polli,Abu T.M. Serajuddin,Jack Cook,Jennifer B. Dressman

Biopharmaceutics
Medicine
Drug
2014
Loading...
    Cite this:
Generate Citation
Powered by Citationsy*
    “The Biopharmaceutics Risk Assessment Roadmap for Optimizing Clinical Drug Product Performance” is a paper by Arzu Selen Paul Dickinson Anette Müllertz John R. Crison Hitesh Mistry María T. Cruañes Marilyn N. Martinez Hans Lennernäs Tim Wigal David C. Swinney James E. Polli Abu T.M. Serajuddin Jack Cook Jennifer B. Dressman published in 2014. It has an Open Access status of “closed”. You can read and download a PDF Full Text of this paper here.
    OA.mgAbout UsOur ValuesWhy OA.mg? OA.mg PremiumChrome ExtensionChatGPT PluginPublic RoadmapChangelogContact UsFeedback?
    Privacy PolicyTerms of ServiceRefund Policy
    ContentOA.mg CoverageTop ListsOpen Access JournalsTopicsBlog
    ExploreGeographyEngineeringPoliSciGeologyPhilosophySociologyArtHistoryMathematicsPhysics
     PsychologyComputer ScienceBusinessEnvironmental ScienceChemistryMaterials ScienceMedicineBiologyEconomics
    OA.mg is built in Stockholm, London, and Seoul. We work hand in hand with the scientific community to advance the cause of Open Access. Feedback makes us better.